• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

认知症状对中国重度抑郁症患者健康相关生活质量和工作生产力的影响:PROACT研究结果

Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT Study.

作者信息

Wang Gang, Tan Kristin Hui Xian, Ren Hongye, Hammer-Helmich Lene

机构信息

Psychiatry Department, Beijing an Ding Hospital, Capital Medical University, China National Clinical Research Center for Mental Disorders, Beijing, People's Republic of China.

Health Economics & Epidemiology Statistics, Lundbeck Singapore Pte Ltd, Singapore.

出版信息

Neuropsychiatr Dis Treat. 2020 Mar 13;16:749-759. doi: 10.2147/NDT.S230403. eCollection 2020.

DOI:10.2147/NDT.S230403
PMID:32214816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7081063/
Abstract

PURPOSE

This post hoc analysis was undertaken to further explore the association of cognitive symptoms with health-related quality of life (HRQoL) and work productivity at the time of treatment initiation in Chinese patients with major depressive disorder (MDD) in the Prospective Research Observation to Assess Cognition in Treated patients with MDD (PROACT) study.

PATIENTS AND METHODS

This was an epidemiological, non-interventional, prospective cohort study in adult outpatients with moderate-to-severe MDD initiating antidepressant monotherapy (first or second line). Crude and adjusted analyses of covariance were performed to assess the association of perceived cognitive symptoms (20-item Perceived Deficits Questionnaire-Depression [PDQ-D] total score) or observed cognitive performance (Digit Symbol Substitution Test [DSST] score) with HRQoL (EuroQoL 5-Dimensions Questionnaire index) and work productivity (Work Productivity and Activity Impairment [WPAI] or Sheehan Disability Scale [SDS] absenteeism and presenteeism scores). Adjusted analyses included depression severity, age, sex, residential area (urban/rural), and educational level.

RESULTS

Of 1008 patients enrolled in the PROACT study, 986 were included in this analysis. Severity of perceived cognitive symptoms (ie, higher PDQ-D total score) was significantly associated with worse HRQoL (<0.001) and higher levels of absenteeism (=0.020 for the WPAI and =0.002 for the SDS) and presenteeism (<0.001 for both scales). The association of perceived cognitive symptoms with HRQoL and presenteeism was independent of depression severity. The association between observed cognitive performance (DSST score) and HRQoL was less robust. No association was seen between observed cognitive performance and levels of absenteeism or presenteeism assessed by either scale.

CONCLUSION

Results of this real-world study illustrate the impact of cognitive symptoms on HRQoL and work productivity in Chinese patients with MDD, and highlight the importance of assessing and targeting cognitive symptoms in order to improve functional outcomes when treating patients with MDD.

摘要

目的

在评估接受治疗的重度抑郁症(MDD)患者认知情况的前瞻性研究观察(PROACT)中,进行此项事后分析以进一步探究中国MDD患者在开始治疗时认知症状与健康相关生活质量(HRQoL)及工作效率之间的关联。

患者与方法

这是一项针对开始接受抗抑郁单药治疗(一线或二线)的中重度MDD成年门诊患者的流行病学、非干预性前瞻性队列研究。进行了粗协方差分析和校正协方差分析,以评估感知到的认知症状(20项感知缺陷问卷 - 抑郁[PDQ - D]总分)或观察到的认知表现(数字符号替换测验[DSST]得分)与HRQoL(欧洲五维健康量表指数)及工作效率(工作效率与活动障碍[WPAI]或希恩残疾量表[SDS]缺勤及出勤表现得分)之间的关联。校正分析纳入了抑郁严重程度、年龄、性别、居住地区(城市/农村)及教育水平。

结果

在PROACT研究纳入的1008例患者中,986例纳入本分析。感知到的认知症状严重程度(即较高的PDQ - D总分)与较差的HRQoL(<0.001)、较高的缺勤水平(WPAI为 =0.020,SDS为 =0.002)及出勤表现(两个量表均<0.001)显著相关。感知到的认知症状与HRQoL及出勤表现之间的关联独立于抑郁严重程度。观察到的认知表现(DSST得分)与HRQoL之间的关联不太显著。未观察到观察到的认知表现与两种量表评估的缺勤或出勤表现水平之间存在关联。

结论

这项真实世界研究的结果说明了认知症状对中国MDD患者HRQoL及工作效率的影响,并强调了在治疗MDD患者时评估及针对认知症状以改善功能结局的重要性。

相似文献

1
Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT Study.认知症状对中国重度抑郁症患者健康相关生活质量和工作生产力的影响:PROACT研究结果
Neuropsychiatr Dis Treat. 2020 Mar 13;16:749-759. doi: 10.2147/NDT.S230403. eCollection 2020.
2
Relationship of cognitive impairment with depressive symptoms and psychosocial function in patients with major depressive disorder: Cross-sectional analysis of baseline data from PERFORM-J.在重性抑郁障碍患者中认知障碍与抑郁症状和心理社会功能的关系:来自 PERFORM-J 的基线数据的横断面分析。
J Affect Disord. 2019 Nov 1;258:172-178. doi: 10.1016/j.jad.2019.07.064. Epub 2019 Jul 30.
3
Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China.重度抑郁症的认知症状:在中国进行的一项为期6个月的非干预性前瞻性研究中与临床和功能结局的关联
Neuropsychiatr Dis Treat. 2019 Jul 1;15:1723-1736. doi: 10.2147/NDT.S195505. eCollection 2019.
4
A cross-sectional study of functional disabilities and perceived cognitive dysfunction in patients with major depressive disorder in South Korea: The PERFORM-K study.韩国重大抑郁障碍患者功能性残疾和认知功能障碍的横断面研究:PERFORM-K 研究。
Psychiatry Res. 2016 May 30;239:353-61. doi: 10.1016/j.psychres.2016.01.022. Epub 2016 Jan 16.
5
Association between baseline cognitive symptoms and the subsequent presenteeism and global function in patients with major depressive disorder.首发认知症状与首发抑郁障碍患者随后的工作效率低下和整体功能之间的关系。
J Psychiatr Res. 2022 Oct;154:324-331. doi: 10.1016/j.jpsychires.2022.07.036. Epub 2022 Jul 31.
6
Validation and Functional Relevance of the Short Form of the Perceived Deficits Questionnaire for Depression for Japanese Patients with Major Depressive Disorder.日本重度抑郁症患者抑郁感知缺陷问卷简表的效度及功能相关性
Neuropsychiatr Dis Treat. 2022 Nov 2;18:2507-2517. doi: 10.2147/NDT.S381647. eCollection 2022.
7
The Effect of Cognitive Impairment on the Prognosis of Major Depressive Disorder.认知障碍对重度抑郁症预后的影响。
J Nerv Ment Dis. 2020 Sep;208(9):683-688. doi: 10.1097/NMD.0000000000001180.
8
Reliability and validity of Chinese version of perceived deficits questionnaire for depression in patients with MDD.中文版抑郁障碍患者感知缺陷问卷的信度和效度。
Psychiatry Res. 2017 Jun;252:319-324. doi: 10.1016/j.psychres.2017.03.021. Epub 2017 Mar 11.
9
Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: Results from the RELIEVE study.在真实临床实践中,文拉法辛在老年抑郁症患者中的疗效:RELIEVE 研究结果。
J Psychopharmacol. 2024 Jul;38(7):615-623. doi: 10.1177/02698811241260996.
10
Relationship of Subjective Cognitive Impairment with Psychosocial Function and Relapse of Depressive Symptoms in Patients with Major Depressive Disorder: Analysis of Longitudinal Data from PERFORM-J.重度抑郁症患者主观认知障碍与心理社会功能及抑郁症状复发的关系:来自PERFORM-J纵向数据的分析
Neuropsychiatr Dis Treat. 2021 Mar 26;17:945-955. doi: 10.2147/NDT.S288108. eCollection 2021.

引用本文的文献

1
Effectiveness of Vortioxetine in Working Patients with Major Depressive Disorder in China: A Subgroup Analysis of the RELIEVE China Study.伏硫西汀在中国患有重度抑郁症的在职患者中的疗效:RELIEVE中国研究的亚组分析
Neuropsychiatr Dis Treat. 2024 Jun 7;20:1211-1223. doi: 10.2147/NDT.S460408. eCollection 2024.
2
Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study.在常规临床实践中,伴或不伴广泛性焦虑障碍的重性抑郁障碍患者使用文拉法辛的疗效:RELIEVE 研究的亚组分析。
J Psychopharmacol. 2023 Mar;37(3):279-288. doi: 10.1177/02698811221132468. Epub 2022 Nov 15.
3
Validation and Functional Relevance of the Short Form of the Perceived Deficits Questionnaire for Depression for Japanese Patients with Major Depressive Disorder.日本重度抑郁症患者抑郁感知缺陷问卷简表的效度及功能相关性
Neuropsychiatr Dis Treat. 2022 Nov 2;18:2507-2517. doi: 10.2147/NDT.S381647. eCollection 2022.
4
The associations between depressive symptoms, functional impairment, and quality of life, in patients with major depression: undirected and Bayesian network analyses.重度抑郁症患者抑郁症状、功能损害与生活质量之间的关联:无向和贝叶斯网络分析
Psychol Med. 2023 Oct;53(14):6446-6458. doi: 10.1017/S0033291722003385. Epub 2022 Nov 9.
5
Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study.伏硫西汀在真实世界临床实践中治疗重度抑郁症的有效性和安全性:单臂RELIEVE中国研究结果
Neuropsychiatr Dis Treat. 2022 Aug 30;18:1939-1950. doi: 10.2147/NDT.S358253. eCollection 2022.
6
Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study.伏硫西汀在现实临床实践中治疗重度抑郁症患者的有效性:RELIEVE研究结果
Front Psychiatry. 2022 Mar 9;13:824831. doi: 10.3389/fpsyt.2022.824831. eCollection 2022.
7
Factors related to retinal nerve fiber layer thickness in bipolar disorder patients and major depression patients.双相情感障碍患者和重度抑郁症患者视网膜神经纤维层厚度的相关因素。
BMC Psychiatry. 2021 Jun 10;21(1):301. doi: 10.1186/s12888-021-03270-7.

本文引用的文献

1
Relationship of cognitive impairment with depressive symptoms and psychosocial function in patients with major depressive disorder: Cross-sectional analysis of baseline data from PERFORM-J.在重性抑郁障碍患者中认知障碍与抑郁症状和心理社会功能的关系:来自 PERFORM-J 的基线数据的横断面分析。
J Affect Disord. 2019 Nov 1;258:172-178. doi: 10.1016/j.jad.2019.07.064. Epub 2019 Jul 30.
2
Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China.重度抑郁症的认知症状:在中国进行的一项为期6个月的非干预性前瞻性研究中与临床和功能结局的关联
Neuropsychiatr Dis Treat. 2019 Jul 1;15:1723-1736. doi: 10.2147/NDT.S195505. eCollection 2019.
3
Canadian economic impact of improved workplace productivity in patients with major depressive disorder treated with vortioxetine.伏硫西汀治疗的重度抑郁症患者工作场所生产力提高对加拿大经济的影响。
CNS Spectr. 2020 Jun;25(3):372-379. doi: 10.1017/S1092852919000853. Epub 2019 May 23.
4
Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study.在接受沃替西汀治疗的有工作的重度抑郁症患者中,认知症状可预测长期功能结局:来自 AtWoRC 研究的结果。
CNS Spectr. 2019 Dec;24(6):616-627. doi: 10.1017/S1092852919000786.
5
Prevalence of mental disorders in China: a cross-sectional epidemiological study.中国精神障碍的患病率:一项横断面流行病学研究。
Lancet Psychiatry. 2019 Mar;6(3):211-224. doi: 10.1016/S2215-0366(18)30511-X. Epub 2019 Feb 18.
6
Are they just exaggerating? Differences between subjective and objective cognitive performance in patients with depression: Mounting evidence and open questions.他们只是在夸大其词吗?抑郁症患者主观与客观认知表现的差异:越来越多的证据及未解决的问题。
J Affect Disord. 2019 Apr 1;248:198-199. doi: 10.1016/j.jad.2018.05.082. Epub 2018 Jun 24.
7
Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder.针对美国和英国重度抑郁症患者的感知缺陷问卷-抑郁版(PDQ-D)工具的心理测量学验证。
Neuropsychiatr Dis Treat. 2018 Oct 29;14:2861-2877. doi: 10.2147/NDT.S175188. eCollection 2018.
8
Four-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence study.美国大型医疗保健系统员工出勤主义数据四年回顾:一项回顾性患病率研究。
Hum Resour Health. 2018 Nov 9;16(1):59. doi: 10.1186/s12960-018-0321-9.
9
The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: A systematic review.重度抑郁症患者认知障碍与社会心理功能的临床关系:系统综述。
Psychiatry Res. 2018 Nov;269:157-171. doi: 10.1016/j.psychres.2018.08.033. Epub 2018 Aug 15.
10
What is the overlap between subjective and objective cognitive impairments in MDD?重度抑郁症中主观认知障碍与客观认知障碍之间的重叠是什么?
Ann Clin Psychiatry. 2018 Aug;30(3):176-184.